Starfire Investment Advisers’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$296K Hold
1,545
0.14% 133
2020
Q1
$227K Hold
1,545
0.12% 136
2019
Q4
$239K Hold
1,545
0.09% 160
2019
Q3
$208K Buy
+1,545
New +$202K 0.09% 166

Other funds holding RMD

Starfire Investment Advisers's RMD Position: Q2 2020 in Review

Starfire Investment Advisers held its ResMed (RMD) position steady in Q2 2020 at 1,545 shares worth $296K. The position accounts for 0.14% of the portfolio, ranked #133.

Starfire Investment Advisers first reported a position in RMD in Q3 2019 and has held it in 4 quarters since. 582 funds tracked by Wall St. Rank hold RMD as of Q2 2020.

  • Starfire Investment Advisers held 1,545 shares of ResMed worth $296K as of Q2 2020.
  • Starfire Investment Advisers left its ResMed share count unchanged in Q2 2020.
  • ResMed made up 0.14% of Starfire Investment Advisers's portfolio in Q2 2020, its #133 holding.
  • Starfire Investment Advisers first reported a position in ResMed in Q3 2019 and has held it in 4 quarters since.
  • 582 funds tracked by Wall St. Rank held ResMed as of Q2 2020.

Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.